Table 1 Data sources
| Data source | Description | Purpose |
|---|---|---|
| Data abstraction | ▪ Data abstracted from clinical delivery tools | ▪ Define profile of screened and initiated on PrEP and whether persons are appropriately put on PrEP |
| Technical assistance reports and rapid cycle debriefs. | ▪ Rapid cycle debriefs and TA reports prepared at baseline and 6-monthly |
▪ Document detailed knowledge of process of integration of PrEP delivery and track changes in PrEP implementation processes ▪ Rapid cycle analysis to convey to facilities for quality improvement |
| Qualitative interviews: women, healthcare providers, and policy key informants | ▪ Purposefully sampled client and key informants involved in the delivery | ▪ Characterize process of adoption and integration of PrEP delivery and track changes in PrEP implementation processes, including barriers and facilities |
| Quantitative surveys |
▪ Healthcare providers ▪ Random cross-sectional exit surveys with women at the end of clinic visit |
▪ Assess acceptability, clinics’ readiness to implement, clinic inner settings ▪ HIV and STI risk perception, characteristics of women accessing through FP clinics, stigma, and satisfaction with services offered. |
| Activity-based costing, and time and motions studies | ▪ Primary data collection | ▪ Activity-based costing, and time and motions studies |
| Clinic and client flow mapping | ▪ Primary data collection | ▪ Establish baseline flow, track how new services are incorporated in the flow and bottlenecks, and document patient wait-time |
| Standardized patient actors | ▪ Standardized clients make unannounced visit to subset of clinics and complete a checklist | ▪ Assess implementation fidelity by documenting type of services offered, quality of services received, and provider attitudes |
| Random blood draw | ▪ Dried blood spots collected at ~10% visits on persons using PrEP | ▪ Objective assessment of PrEP adherence (tenofovir levels) |
| Nested observational cohort | ▪ Women identified as eligible for PrEP, both who initiate and those who decline | ▪ Detailed individual-level outcomes: HIV risk behaviors, HIV risk perception, HIV incidence, HIV prevention decision making, contraception use, stigma, STI burden, PrEP retention, and reasons for discontinuation |